Product Data Sheet

Fenirofibrate impurity 3

Catalog No. B10456

main product photo
Fenirofibrate impurity 3 is a structural byproduct of Fenirofibrate, a medication primarily used to treat lipid disorders. This impurity is critical for quality control and analytical studies in pharmaceutical research, ensuring the safety and efficacy of the drug. Additionally, it serves as a reference material in the characterization and analysis of Fenirofibrate formulations.
Chemical Information
Catalog NumB10456
M. Wt362.85
FormulaC20H23ClO4
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.61001-99-8
Synonyms
SMILESO=C(OC(C)C)C(OC1=CC=C(C=C1)C(O)C2=CC=C(Cl)C=C2)(C)C
Biological Activity
DescriptionFenirofibrate impurity 3 is a structural byproduct of Fenirofibrate, a medication primarily used to treat lipid disorders. This impurity is critical for quality control and analytical studies in pharmaceutical research, ensuring the safety and efficacy of the drug. Additionally, it serves as a reference material in the characterization and analysis of Fenirofibrate formulations.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.